X4 Pharmaceuticals (XFOR) Return on Invested Capital (2020 - 2025)

X4 Pharmaceuticals has reported Return on Invested Capital for 6 years, with the latest figure at 0.0% in Q4 2025.

• For the quarter ending Q4 2025, Return on Invested Capital changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Dec 2025 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital for Q4 2025 stood at 0.0%, up from 0.01% in the prior quarter.
• The five-year high for Return on Invested Capital was 0.0% in Q1 2025, with the low at 0.01% in Q1 2024.
• Historically, Return on Invested Capital has averaged 0.01% across 5 years, with a median of 0.01% in 2025.
• Annual changes were most pronounced in 2022 — Return on Invested Capital slipped 1 bps — and 2024, when it gained 1 bps.
• X4 Pharmaceuticals' Return on Invested Capital stood at 0.01% in 2021, then declined by 1 bps to 0.01% in 2022, then slipped by 8 bps to 0.01% in 2023, then surged by 66 bps to 0.0% in 2024, then slumped by 38 bps to 0.0% in 2025.
• The last three Return on Invested Capital figures came in at 0.0% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025), per Business Quant data.